G

Glaukos Corp
D

GKOS

143.880
USD
3.06
(2.17%)
Market Closed
Volume
18,071
EPS
-2
Div Yield
-
P/E
-49
Market Cap
7,933,173,285
Related Instruments
    A
    ALGN
    2.230
    (1.01%)
    223.930 USD
    A
    ATEC
    -0.50000
    (-5.72%)
    8.23500 USD
    EW
    EW
    1.620
    (2.45%)
    67.780 USD
    I
    ICUI
    -4.120
    (-2.40%)
    167.760 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    547.83 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.14 USD
    MDT
    MDT
    1.520
    (1.77%)
    86.2 USD
    N
    NUVA
    -0.720
    (-1.77%)
    39.980 USD
    SYK
    SYK
    6.90
    (1.80%)
    384.88 USD
    More
News

Title: Glaukos Corp

Sector: Healthcare
Industry: Medical Devices
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.